Vanda Pharmaceuticals to Participate in B. Riley Securities Summit
Vanda Pharmaceuticals announced its participation in the B. Riley Securities Mind, Muscle & Vision Summit in Boston on July 16, 2026. The company will deliver a fireside chat presentation.

Vanda Pharmaceuticals Inc. (Vanda) has announced that it will participate in the B. Riley Securities Mind, Muscle & Vision Summit, taking place in Boston, Massachusetts. The company's representatives are scheduled to present a fireside chat on Thursday, July 16.
The summit brings together financial professionals and healthcare companies, providing a forum for discussions on developments within the mind, muscle, and vision sectors. Vanda's involvement in this event is part of its ongoing effort to communicate its progress and market perspectives to investors and industry stakeholders.
Vanda Pharmaceuticals operates as a biopharmaceutical company concentrating on the development and commercialization of treatments designed to address significant unmet medical needs and enhance patient well-being.
The company's participation is expected to offer insights into its strategic direction and future outlook within the pharmaceutical landscape.